Rabeprazole Extended-Release, 50 mg, Versus Esomeprazole, 40 mg, for Healing and Symptomatic Relief of Moderate to Severe Erosive Gastroesophageal Reflux Disease (GERD)

Completed · Phase 3

Conditions studied: Gastroesophageal Reflux Disease (GERD)

In brief

The purpose of this study is to investigate the efficacy (ie, healing and symptom relief) and safety of Rabeprazole Extended-Release (RAB ER) 50 mg versus Esomeprazole (ESO) 40 mg for the treatment of moderate to severe erosive Gastroesophageal Reflux Disease (eGERD).

Key facts

Study ID

NCT00658775

Run by

Eisai Inc.

People needed

1069

Starts

2008-02-01

Expected to finish

2010-01-01

Last updated by the study team

2015-12-21

Who can join

Age: 18 and older, up to 75. Sex: any. Healthy volunteers: not accepted.

Where it is running

• Study site — La Plata, Argentina, Argentina
• Study site — Buenos Aires, BUE, Argentina
• Study site — Buenos Aires, BUE, Argentina
• Study site — Ciudad Autonoma de Bs. As., CBA, Argentina
• Study site — Ciudad Autonoma de Bs. As., CBA, Argentina
• Study site — Ciudad Autonoma de Bs. As., CBA, Argentina
• Study site — Rosario, SFE, Argentina
• Study site — San Miguel de Tucumán, TUC, Argentina
• Study site — Penrith, New South Wales, Australia
• Study site — Caboolture, Queensland, Australia
• Study site — Adelaide, South Australia, Australia
• Study site — Woodville, South Australia, Australia
• Study site — Launceston, Tasmania, Australia
• Study site — Ballarat, Victoria, Australia
• Study site — Fitzroy, Victoria, Australia
• Study site — Haskovo, Bulgaria, Bulgaria
• Study site — Plovdiv, Bulgaria, Bulgaria
• Study site — Rousse, Bulgaria, Bulgaria
• Study site — Sofia, Bulgaria, Bulgaria
• Study site — Sofia, Bulgaria, Bulgaria
• Study site — Barrie, Ontario, Canada
• Study site — Chatham, Ontario, Canada
• Study site — Hamilton, Ontario, Canada
• Study site — Richmond Hill, Ontario, Canada
• Study site — Moline, Illinois, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.